首页> 美国卫生研究院文献>PLoS Clinical Trials >Amiloride Enhances Antigen Specific CTL by Faciliting HBV DNA Vaccine Entry into Cells
【2h】

Amiloride Enhances Antigen Specific CTL by Faciliting HBV DNA Vaccine Entry into Cells

机译:阿米洛利通过促进HBV DNA疫苗进入细胞增强抗原特异性CTL

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The induction of relatively weak immunity by DNA vaccines in humans can be largely attributed to the low efficiency of transduction of somatic cells. Although formulation with liposomes has been shown to enhance DNA transduction of cultured cells, little, if any, effect is observed on the transduction of somatic tissues and cells. To improve the rate of transduction, DNA vaccine delivery by gene gun and the recently developed electroporation techniques have been employed. We report here that to circumvent requirement for such equipment, amiloride, a drug that is prescribed for hypertension treatment, can accelerate plasmid entry into antigen presenting cells (APCs) both in vitro and in vivo. The combination induced APCs more dramatically in both maturation and cytokine secretion. Amiloride enhanced development of full CD8 cytolytic function including induction of high levels of antigen specific CTL and expression of IFN-γ+perforin+granzymeB+ in CD8+ T cells. Thus, amiloride is a facilitator for DNA transduction into host cells which in turn enhances the efficiency of the immune responses.
机译:DNA疫苗在人体内诱导的免疫力相对较弱,在很大程度上可归因于体细胞转导效率低。尽管已显示用脂质体配制可增强培养细胞的DNA转导,但对体组织和细胞转导几乎没有影响。为了提高转导率,已采用通过基因枪和最近开发的电穿孔技术递送DNA疫苗。我们在此报告,为了规避此类设备的需求,阿米洛利(一种用于高血压治疗的药物)可以在体外和体内加速质粒进入抗原呈递细胞(APC)的进入。该组合在成熟和细胞因子分泌方面均诱导APC更为显着。阿米洛利增强了完整CD8溶细胞功能的发展,包括诱导高水平的抗原特异性CTL以及CD8 + T细胞中IFN-γ+ perforin + granzymeB +的表达。因此,阿米洛利是DNA转导进入宿主细胞的促进剂,继而提高了免疫反应的效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号